TY - JOUR
T1 - Achieved clinic blood pressure level and chronic kidney disease progression in children
T2 - a report from the Chronic Kidney Disease in Children cohort
AU - Flynn, Joseph T.
AU - Carroll, Megan K.
AU - Ng, Derek K.
AU - Furth, Susan L.
AU - Warady, Bradley A.
N1 - Funding Information:
The CKiD Study is supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases, with additional funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Heart, Lung, and Blood Institute (U01 DK066143, U01 DK066174, U24 DK082194, U24 DK066116). Acknowledgments
Funding Information:
Joseph Flynn reports grants from the American Heart Association, personal fees from Silvergate Phamaceuticals, Ultragenyx, Springer, and Up To Date outside the published work. All other authors declare that they have no conflict of interest.
Funding Information:
Data in this manuscript were collected by the Chronic Kidney Disease in Children prospective cohort study (CKiD) with clinical coordinating centers (Principal Investigators) at Children?s Mercy Hospital and the University of Missouri - Kansas City (Bradley Warady, MD) and Children?s Hospital of Philadelphia (Susan Furth, MD, PhD), Central Biochemistry Laboratory (George Schwartz, MD) at the University of Rochester Medical Center, and data coordinating center (Alvaro Mu?oz, PhD and Derek K. Ng, PhD) at the Johns Hopkins Bloomberg School of Public Health. The CKiD website is located at https://statepi.jhsph.edu/ckid. The authors thank Michelle C. Starr, MD, MPH for her help with creation of the visual abstract.
Publisher Copyright:
© 2020, IPNA.
PY - 2021/6
Y1 - 2021/6
N2 - Background: Control of hypertension delays progression of pediatric chronic kidney disease (CKD), yet few data are available regarding what clinic blood pressure (BP) levels may slow progression. Methods: Longitudinal BP data from children in the Chronic Kidney Disease in Children cohort study who had hypertension or an auscultatory BP ≥ 90th percentile were studied. BP categories were defined as the maximum systolic or diastolic BP percentile (< 50th, 50th to 75th, 75th to 90th, and ≥ 90th percentile) with time-updated classifications corresponding to annual study visits. The primary outcome was time to kidney replacement therapy or a 30% decline in estimated glomerular filtration rate. Cox proportional hazard models described the effect of each BP category compared to BP ≥ 90th percentile. Results: Seven hundred fifty-four participants (median age 9.9 years at study entry) met inclusion criteria; 65% were male and 26% had glomerular CKD. Any BP < 90th percentile was associated with a decreased risk of progression for those with glomerular CKD (hazard ratio (HR), 0.63; 95% CI, 0.28–1.39 (< 50th); HR, 0.59; 95% CI, 0.28–1.26 (50th–75th); HR, 0.40; 95% CI, 0.18–0.93 (75th–90th)). Similar results were found for those with non-glomerular CKD: any BP < 90th percentile was associated with decreased risk of progression (HR, 0.78; 90% CI, 0.49–1.25 (< 50th); HR, 0.53; 95% CI, 0.33–0.84 (50th–75th); HR, 0.71; 95% CI, 0.46–1.08 (75th–90th)). Conclusions: Achieved clinic BP < 90th percentile was associated with slower CKD progression in children with glomerular or non-glomerular CKD. These data provide guidance for management of children with CKD in the office setting. [Figure not available: see fulltext.]
AB - Background: Control of hypertension delays progression of pediatric chronic kidney disease (CKD), yet few data are available regarding what clinic blood pressure (BP) levels may slow progression. Methods: Longitudinal BP data from children in the Chronic Kidney Disease in Children cohort study who had hypertension or an auscultatory BP ≥ 90th percentile were studied. BP categories were defined as the maximum systolic or diastolic BP percentile (< 50th, 50th to 75th, 75th to 90th, and ≥ 90th percentile) with time-updated classifications corresponding to annual study visits. The primary outcome was time to kidney replacement therapy or a 30% decline in estimated glomerular filtration rate. Cox proportional hazard models described the effect of each BP category compared to BP ≥ 90th percentile. Results: Seven hundred fifty-four participants (median age 9.9 years at study entry) met inclusion criteria; 65% were male and 26% had glomerular CKD. Any BP < 90th percentile was associated with a decreased risk of progression for those with glomerular CKD (hazard ratio (HR), 0.63; 95% CI, 0.28–1.39 (< 50th); HR, 0.59; 95% CI, 0.28–1.26 (50th–75th); HR, 0.40; 95% CI, 0.18–0.93 (75th–90th)). Similar results were found for those with non-glomerular CKD: any BP < 90th percentile was associated with decreased risk of progression (HR, 0.78; 90% CI, 0.49–1.25 (< 50th); HR, 0.53; 95% CI, 0.33–0.84 (50th–75th); HR, 0.71; 95% CI, 0.46–1.08 (75th–90th)). Conclusions: Achieved clinic BP < 90th percentile was associated with slower CKD progression in children with glomerular or non-glomerular CKD. These data provide guidance for management of children with CKD in the office setting. [Figure not available: see fulltext.]
KW - Adolescents
KW - Children
KW - Chronic kidney disease
KW - Cohort study
KW - Glomerular filtration rate
KW - Hypertension
UR - http://www.scopus.com/inward/record.url?scp=85096063856&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096063856&partnerID=8YFLogxK
U2 - 10.1007/s00467-020-04833-8
DO - 10.1007/s00467-020-04833-8
M3 - Article
C2 - 33200315
AN - SCOPUS:85096063856
SN - 0931-041X
VL - 36
SP - 1551
EP - 1559
JO - Pediatric Nephrology
JF - Pediatric Nephrology
IS - 6
ER -